(Total Views: 567)
Posted On: 01/03/2022 11:07:50 AM
Post# of 148902
Ohm, have any thought on GLSI?
"If the patient completed the Primary Immunization Serie, the 5-year disease-free survival rate in the 46 HER2 3+ patients treated with GLSI-100 was 100% versus 89.4% in the 50 placebo patients treated with GM-CSF"
https://markets.businessinsider.com/news/stoc...1031036746
"If the patient completed the Primary Immunization Serie, the 5-year disease-free survival rate in the 46 HER2 3+ patients treated with GLSI-100 was 100% versus 89.4% in the 50 placebo patients treated with GM-CSF"
https://markets.businessinsider.com/news/stoc...1031036746
(0)
(0)Scroll down for more posts ▼
